Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers

Author： Spurdle Amanda  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.122, Iss.1, 2010-07, pp. : 281-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers

By Bernholtz Shiri  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 981-985

Springer Publishing Company

Access to resources Recommend Favorite

The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

By Kaufman Bella  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 521-527

Springer Publishing Company

Access to resources Recommend Favorite

Genetic polymorphisms in glutathione S-transferases P1 (GSTP1) Ile105Val and prostate cancer risk: a systematic review and meta-analysis

By Cai Qiliang   Wu Tao   Zhang Wei   Guo Xuemei   Shang Zhiqun   Jiang Ning   Tian Jing   Niu Yuanjie  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3913-3922

Springer Publishing Company

Access to resources Recommend Favorite

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 241-242

Informa Healthcare

Access to resources Recommend Favorite

Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

By Kotsopoulos Joanne  

Cancer Causes and Control, Vol. 16, Iss. 6, 2005-08 ,pp. : 667-674

Springer Publishing Company

Access to resources Recommend Favorite